Statement from Caregiver Action Network CEO Marvell Adams Jr. on “Most-Favored Nation” Drug Pricing
Statement from Caregiver Action Network CEO Marvell Adams Jr. on “Most-Favored Nation” Drug Pricing
May 9, 2025
WASHINGTON D.C. — Caregiver Action Network strongly opposes any Medicaid proposals that adopt a “most-favored nation” (MFN) drug pricing model, which would tie U.S. drug prices to those in foreign countries. While addressing the rising cost of prescription drugs is essential, this approach would ultimately do more harm than good—especially for family caregivers and the loved ones they support.
People on Medicaid already have broad access to medicines at little to no cost-sharing. The MFN model could lead to cuts in Medicaid and reduced access to lifesaving treatments for vulnerable populations.
Family caregivers already navigate complex healthcare systems while bearing significant financial strain. Policies that create additional barriers to affordable medications only add to their burden.
We urge policymakers to reject MFN-based proposals and instead collaborate with caregivers and patient advocates to develop solutions that prioritize access, affordability, and equity in healthcare.
— Marvell Adams Jr., CEO, Caregiver Action Network
About Caregiver Action Network (CAN):
Caregiver Action Network is the nation’s leading family caregiver organization, dedicated to improving the quality of life for millions of caregivers. CAN provides education, peer support, and resources at no cost to family caregivers across the United States. Its programs support caregivers of individuals with chronic conditions, disabilities, and rare diseases, including those navigating the complexities of genetic testing and diagnosis.